The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Azithromycin Use Cuts Cesarean Infections

Azithromycin has been shown to lower the risk for postoperative infection during cesarean deliveries when added to more standard prophylactics such as cefazolin.

Diphtheria Debate Exposes Health Misinformation

A diphtheria death in Sicily has reignited debate over vaccines, migration, and how political spin can distort public health facts.

AI Digital Twins Get Better and Better: Cancer in Crosshairs

Digital twins allow doctors to simulate treatment to see what will work best — and the tech has made real strides in cardiology. Oncology remains the bigger challenge.

Methotrexate for IBD: How Do GIs Use It?

A new study offers the most comprehensive real-world look yet at methotrexate use in treating IBD in everyday practice.

As-Needed Allergic Rhinitis Meds Comparable to Daily Use

Patients with allergic rhinitis who use medication as needed can achieve symptom control and treatment satisfaction comparable to those achieved by patients who use them daily.

S1P Modulators: 5 Agents, One Safety Playbook

Five S1P modulators now span neurology and GI. Bruce Cree, MD, PhD, and others weigh in on why selectivity differences are no longer academic.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

Azithromycin has been shown to lower the risk for postoperative infection during cesarean deliveries when added to more standard prophylactics such as cefazolin.

A diphtheria death in Sicily has reignited debate over vaccines, migration, and how political spin can distort public health facts.

Digital twins allow doctors to simulate treatment to see what will work best — and the tech has made real strides in cardiology. Oncology remains the bigger challenge.

A new study offers the most comprehensive real-world look yet at methotrexate use in treating IBD in everyday practice.

Patients with allergic rhinitis who use medication as needed can achieve symptom control and treatment satisfaction comparable to those achieved by patients who use them daily.

Five S1P modulators now span neurology and GI. Bruce Cree, MD, PhD, and others weigh in on why selectivity differences are no longer academic.

News All Time

Clinicians Should Be on Alert for Measles in Adults

Data suggests that infected adults are being hospitalized as often, or more than, children younger than 5 years.

Enhancing Quality of Life for Terminally Ill Veterans

Honoring individualized preferences for end-of-life interventions for veterans is a priority for families and caregivers; this study explores various nonpharmacologic interventions.

US FDA Extends Review Of Exelixis' Cancer Drug

The U.S. Food and Drug Administration has extended the review of Exelixis' experimental colorectal cancer drug combination ⁠by three months, the company said in a filing on...

CDC Issues Alert on Rabies Exposure, Appropriate Treatment

The agency expresses concern that a rise in use of postexposure prophylaxis could indicate a lack of understanding of when to administer the therapy.

Backlogs, Testing Gaps in Medicare AI Prior Auth Pilot

Internal documents show contractor readiness concerns, decision delays, and high non-affirmation rates, while providers report patients waiting for care and payment problems.

Food Allergies Linked to Eating Disorder History

Screening for eating disorders may help clinicians identify when food avoidance in patients with allergies extends beyond necessary dietary restrictions.

Missing Piece of the Thymus/Immune System Puzzle May Be Age

Researchers took a new tack investigating how the thymus affects immune system function and immunotherapy effectiveness: using aged mice. The results were eye-opening.

Alopecia Areata Consensus Statement Recommends First-Line Rx

An expert consensus panel has offered the first-ever standardized, evidence-based recommendations for the management of alopecia areata, identifying JAK inhibitors as the first-line therapy.

Mycobacteria Linked to Worse Lung Transplant Outcomes

In lung transplant recipients, detecting nontuberculous mycobacteria in the first year after a transplant may signal heightened risks for death or a repeat transplant and for chronic graft decline.

Stem Cells Improve Sight — and Open New Possibilities

People with a progressive genetic eye disorder see more clearly after receiving engineered grafts that repair the damaged surfaces of their eyes, offering a glimpse at what future treatments could hold.

VTE Rare in Burn Patients on LMWH Prophylaxis

A 12-year study of patients hospitalized for burns receiving pharmacologic prophylaxis finds that venous thromboembolism occurs in < 2% of patients overall.

Fluticasone Improves Sinusitis Across Disease Profiles

Fluticasone delivered via an exhalation system reduces symptoms and improves quality of life in adults with chronic rhinosinusitis, across inflammatory endotypes and comorbidities, a study shows.

Fall Allergy Season Becoming a Moving Target

An early pollen season means earlier onset of allergy symptoms and earlier patient visits for relief.

Early MRI Detects Brain Injury in Newborns With HIE

MRI performed during therapeutic hypothermia accurately identifies the pattern and severity of brain injury in newborns with hypoxic-ischemic encephalopathy.

Syncope or Fall? A Practical Risk Approach in Older Adults

Experts say witness accounts, ECG findings, and simple risk scores can help clinicians distinguish syncope from a mechanical fall.

Evommune Scraps Eczema Drug After Trial Miss, Shares Plunge

Evommune said on Tuesday it will not advance its experimental skin disease ⁠drug after it failed to meet the main goal in a mid-stage trial, ⁠sending its shares down 24% in...

Recommended News For You

Dementia-like protein buildup found in pancreas cells before cancer develops

Year in Review: Chronic Lymphocytic Leukemia

Mezigdomide Combinations Show Promise in Multiple Myeloma

Study looks into cancer-related harmful communication.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

A small rise in cancer was observed following the 1986 Chernobyl accident.

Recommended Articles For You

Precision Risk Mapping in Cancer Prevention Programs 

Case Learning from Acquired Platelet Function Disorders 

Modern Oncology Education in the Era of Targeted Therapies 

Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Clinical trial is testing whether heavy lifting could combat cancer side effects

2.

The most precise research tools for the deadliest blood cancer have been developed.

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

5.

Taking vitamin D daily decreased cancer mortality, according to a study.

1.

Molecular Matching for Individualized Blood-Disorder Therapy

2.

Cemiplimab: A Revolutionary Drug For Treating Cancer

3.

Emerging Therapies Through Engineered Blood Cell Manufacturing Platforms

4.

Care Coordination in Chronic Anemia: Mechanisms, Clinical Implications, and Emerging Strategies

5.

From Bruises to Blood Clots: Everything You Need to Know about Hematoma 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

2.

Thromboprophylaxis In Medical Settings

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

5.

When Unexplained Bruising May Require Blood Testing

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot